Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Vanda Pharmaceuticals Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 140 | 1 | 150 | +11 |
| Shares | 45.0M | 115.0K | 44.9M | +17.4K (0.0%) |
| Value | $212.4M | $542.8K | $224.0M | +$12.2M (+5.8%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qube Research & Technologies Ltd | 179,252 | $894.5K | 0.00% |
| Jump Financial, LLC | 138,000 | $688.6K | 0.01% |
| Panagora Asset Management Inc | 115,059 | $574.1K | 0.00% |
| Cubist Systematic Strategies, LLC | 63,821 | $318.5K | 0.00% |
| PharVision Advisers, LLC | 57,037 | $284.6K | 0.16% |
| Deutsche Bank AG | 50,636 | $252.7K | 0.00% |
| Algert Global LLC | 34,934 | $174.3K | 0.00% |
| Mercer Global Advisors Inc | 28,993 | $144.7K | 0.00% |
| Readystate Asset Management LP | 27,610 | $137.8K | 0.01% |
| State of Wyoming | 27,301 | $136.2K | 0.02% |
| Wealth Enhancement Advisory Services, LLC | 17,500 | $93.0K | 0.00% |
| Mariner, LLC | 17,395 | $86.8K | 0.00% |
| Inscription Capital, LLC | 16,232 | $81.0K | 0.01% |
| Boothbay Fund Management, LLC | 14,446 | $72.1K | 0.00% |
| HRT Financial LP | 11,280 | $56.0K | 0.00% |
| Quarry LP | 10,702 | $53.4K | 0.01% |
| Allworth Financial LP | 832 | $4.15K | 0.00% |
| Optiver Holding B.V. | 476 | $2.38K | 0.00% |
| Point72 Europe (London) LLP | 245 | $1.22K | 0.00% |
| Sunbelt Securities, Inc. | 77 | $384 | 0.00% |
| Advisory Services Network, LLC | 21 | $105 | 0.00% |
| Larson Financial Group LLC | 8 | $40 | 0.00% |
| Summit Wealth Group LLC | 1,843 | – | – |
Sold out (12)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Schroder Investment Management Group | 307,176 | $1.45M |
| Walleye Capital LLC | 94,298 | $445.1K |
| Los Angeles Capital Management LLC | 44,696 | $211.0K |
| StoneX Group Inc. | 20,000 | $94.4K |
| UBS Asset Management Americas Inc | 17,565 | $82.9K |
| R Squared Ltd | 17,556 | $82.9K |
| EntryPoint Capital, LLC | 17,520 | $82.7K |
| Virtu Financial LLC | 12,455 | $59.0K |
| Wolverine Trading, LLC | 11,417 | $54.6K |
| CarsonAllaria Wealth Management, Ltd. | 160 | $755 |
| Fifth Third Bancorp | 153 | $722 |
| Hughes Financial Services, LLC | 121 | $511 |
Not filed for Q3 2025 yet (1)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 115,000 | $542.8K |